MDMX: a novel p53‐binding protein with some functional properties of MDM2.

p53 Mutations in Human Cancers

Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018

p53, guardian of the genome

Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995

Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms

Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113

Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53

Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456

The P-loop — a common motif in ATP- and GTP-binding proteins

Saraste, M., Sibbald, P. R., & Wittinghofer, A. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90281-f · Cited by 2,099

Amplification of a gene encoding a p53-associated protein in human sarcomas

Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949

Decoding the Central Dogma: Quantitative Insights into Transcription and Translation Dynamics in the p53-Mediated DNA Damage Response

François, J., Jambhekar, A., & Lahav, G. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169436 · Cited by 4

The MDMX acidic domain competes with the p53 transactivation domain for MDM2 N-terminal domain binding

Song, Q., Liu, X., & Rainey, J. K. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119319 · Cited by 4

EBNA1 Upregulates P53-Inhibiting Genes in Burkitt's Lymphoma Cell Line

Hashemi, S. M. A., Moradi, A., Hosseini, S. Y., Nikoo, H. R., Bamdad, T., Razmkhah, M., Sarvari, J., & Tabarraei, A. (2023) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.11.4.672 · Cited by 4

Insights into the binding mechanisms of inhibitors of MDM2 based on molecular dynamics simulations and binding free energy calculations

Zhao, P. T., Cao, H., Chen, Y., & Zhu, T. (2019) · Chemical Physics Letters · doi:10.1016/j.cplett.2019.05.001 · Cited by 4

The role of miRNAs in MDMX‐p53 interplay

Yu, D., Xu, Z., Cheng, X., & Qin, J. (2021) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12428 · Cited by 4

MDM4: What do we know about the association between its polymorphisms and cancer?

Almeida, G. M., Castilho, A. C., Adamóski, D., & Braun-Prado, K. (2022) · Medical Oncology · doi:10.1007/s12032-022-01929-z · Cited by 4

MDMX under stress: the MDMX-MDM2 complex as stress signals hub

de Polo, A., Vivekanandan, V., Little, J. B., & Yuan, Z.-M. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.12.18 · Cited by 4

Ubiquitin Family Members in the Regulation of the Tumor Suppressor p53

Xirodimas, D. P., & Scheffner, M. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_10 · Cited by 5

Small Molecules As pro-apoptotic Anticancer Agents

Seneci, P. (2012) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.12.41 · Cited by 4

Restoration of wild-type p53 in drug-resistant mouse breast cancer cells leads to differential gene expression, but is not sufficient to overcome the malignant phenotype

Gottschalk, B., & Klein, A. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1643-5 · Cited by 4

Interaction of p53 with Cellular Proteins

Keller, D. M., Zeng, S. X., & Lu, H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-408-5:121 · Cited by 4

HDM2 and HDMX Proteins in Human Cancer

Hároníková, L., & Vojtěšek, B. (2018) · Klinicka onkologie · doi:10.14735/amko20182s63 · Cited by 4

The Correlation of Mouse Double Minute 4 (MDM4) Polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with Cancer Susceptibility: A Meta-Analysis

Chen, J., Li, X., Liu, R., Xie, Y., Liu, Z., Xiong, H., & Li, Y. (2022) · Medical Science Monitor · doi:10.12659/msm.935671 · Cited by 4

A triple-action PROTAC for wild-type p53 cancer therapy

Bird, G. H., Adhikary, U., Schmidt, M. J., Godes, M., Tesar, B. M., Camara, C. M., Paulo, J. A., Vidlak, J. F., DeAngelo, T. M., Marquez, M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102467 · Cited by 4

JAK2/STAT3-dependent regulation of MDM4/MDM2-p53 signaling in methotrexate-induced ferroptosis and nephrotoxicity

Cheng, Y., Zhao, M., Zhang, Y., Liu, M., & Zhao, L. (2026) · Archives of Pharmacal Research · doi:10.1007/s12272-026-01599-9 · Cited by 3

Cellular, Structural Basis, and Recent Progress for Targeting Murine Double Minute X (MDMX) in Tumors

Yin, Q., Hu, Y., Dong, Z., Lu, J., & Wang, H. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00913 · Cited by 3

What Features of Ligands Are Relevant to the Opening of Cryptic Pockets in Drug Targets?

Xia, Z., Karpov, P., Popowicz, G. M., Sattler, M., & Tetko, I. V. (2022) · Informatics · doi:10.3390/informatics9010008 · Cited by 3

A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity

Cetkovská, K., Šustová, H., Kosztyu, P., & Uldrijan, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144753 · Cited by 3

Atomistic Insights Into the Regulatory Mechanisms Mediated by Post- Translational Modifications: Molecular Dynamics Investigations

Papaleo, E., Casiraghi, N. A., Arrigoni, A., & Ranzani, V. (2012) · Current Physical Chemistry · doi:10.2174/1877946811202040344 · Cited by 3

Targeting the MDM2–p53 Protein–Protein Interaction

Hardcastle, I. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00013-9 · Cited by 3

EEF1A2 inhibiert über eine PI3K/AKT/mTOR-abhängige Stabilisierung von MDM4 die p53-Funktion im Leberzellkarzinom

Longerich, T. (2014) · Der Pathologe · doi:10.1007/s00292-014-2007-y · Cited by 2

RING Fingers and Relatives: Determinators of Protein Fate

Lorick, K. L., Tsai, Y. C., Yang, Y., & Weissman, A. M. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch4 · Cited by 3

A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells

Feng, S., Kong, R., Wang, C., Hao, Q., Xie, X., Wang, H., Han, J., Zhang, Y., Elsner, J., Mendy, D., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02647-x · Cited by 3

Structural Adaptation of Secondary P53 Binding Sites on Mdm2 and Mdmx

Higbee, P. S., Dayhoff, G. W., Anbanandam, A., Varma, S., & Daughdrill, G. W. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168626 · Cited by 2

MDMX enhances radiosensitivity in lung adenocarcinoma and squamous cell carcinoma by inhibiting P53-mediated autophagy

Ji, N.-N., Li, S.-N., Shao, L., Li, Q., Xu, J.-N., & Zeng, Y. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01065-6 · Cited by 2

Cooperation between MDM2 and MDMX in the Regulation of p53

Blaydes, J. P. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_6 · Cited by 2

Mutant p53-Driven Tumorigenesis

Terzian, T., & Lozano, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8_5 · Cited by 2

Tumor Suppressors p53 and TGFβ Converge to Regulate the Alpha-Fetoprotein Oncodevelopmental Tumor Marker

Wilkinson, D. S., & Barton, M. C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_20 · Cited by 2

Comparative proteomics study of proteins involved in induction of higher rates of cell death in mitoxantrone-resistant breast cancer cells MCF-7/MX exposed to TNF-α.

Norouzi, S., Robati, R. Y., Ghandadi, M., Abnous, K., Behravan, J., & Mosaffa, F. (2020) · PubMed Central · doi:10.22038/ijbms.2020.40029.9486 · Cited by 2

Experimental drugs in clinical trials for acute myeloid leukemia: innovations, trends, and opportunities

Gołoś, A., Góra‐Tybor, J., & Robak, T. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2171860 · Cited by 2

Murine double minute X plays a central role in leukemic transformation and may be a promising target for leukemia prevention strategies

Ueda, K. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.04.001 · Cited by 2

Hsa_circ_0023826 protects against glaucoma by regulating miR-188-3p/MDM4 axis

Qu, B., Wang, J., Li, Y., Wu, X., & Zhang, M. (2023) · Acta Biochimica Polonica · doi:10.18388/abp.2020_6322 · Cited by 2

Az akut mieloid leukémia kezelésének új lehetőségei: út a személyre szabott terápiás stratégiák felé

Szakács, Z., & Alizadeh, H. (2022) · Hematológia–Transzfuziológia · doi:10.1556/2068.2022.00151 · Cited by 2

What We Currently Know about the Structure and Function of the p53 Homologue - p73 Protein: Facts, Hypotheses and Expectations

Češková, P., Valík, D., & Vojtěšek, B. (2003) · Folia Biologica · doi:10.14712/fb2003049010001 · Cited by 1

Arnie Levine and the MDM2–p53 discovery: a postdoctoral fellow’s perspective

Zambetti, G. P. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz073 · Cited by 1

Cancer-associated MDM2 W329G mutant attenuates ribosomal stress-mediated p53 responses to promote cell survival and glycolysis

Lien, S. (2024) · American Journal of Cancer Research · doi:10.62347/qifc4021 · Cited by 1

In Situ Study of p53, MDM2, and MDMX Protein Interaction in Living Cells Using Fluorescence Triple Correlation Spectroscopy

Lu, X., Zang, K., Diao, C., Dong, C., & Ren, J. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c08142 · Cited by 1

Drugging p53 mutants: Recent advances using small-molecule modulation strategies

Lopes, E. A., Monteiro, T. G., & Santos, M. M. M. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119149 · Cited by 1

MDM2 and MDMX Regulators of p53 Activity

Momand, J. A., Aspuria, P. J., & Furuta, S. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_7 · Cited by 1

Technology of Wheat Cell-Free-Based Protein Array for Biochemical Analyses of Protein Kinases and Ubiquitin E3 Ligases

Takahashi, H., Nemoto, K., Abdelaziz, R., Uematsu, A., & Sawasaki, T. (2015) · Springer eBooks · doi:10.1007/978-4-431-55561-2_4 · Cited by 1

Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility

LiuXiaohu, J., Li, T., LuJuan, C., Zhou, S., & Yang, Q. Y. (2013) · Cited by 1

Recent Advancements on the Anti-Tumor Small Molecule Inhibitors Targeting the p53-MDM2 Interaction

丁, 涵. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1381881 · Cited by 1

Targeting Hdm2 and Hdm4 in Anticancer Drug Discovery: Implications for Checkpoint Inhibitor Immunotherapy

Ntwasa, M. M. (2024) · Cells · doi:10.3390/cells13131124 · Cited by 2

Cell Cycle Regulation and DNA Damage

Sakasai, R., & Tibbetts, R. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-2561-6_5 · Cited by 1

Correlation between P53 Arg72Pro and MDM4 gene rs4245739 polymorphisms in breast cancer

Pedram, N., Pouladi, N., Feizi, M. A. H., Gavgani, R. R., Asadi, M., Bornehdeli, S., & Sakhinia, E. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100785 · Cited by 1

Preliminary evaluation of a small interfering RNA molecular probe targeting murine double minute 2 in breast cancer

Wang, X., Xu, P., Jiao, Y., Luan, S., Gao, Y., Zhao, C., & Fu, P. (2022) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001582 · Cited by 1

Complex regulation of Forkhead Box O transcription factors

van den Berg, M. C. W. (2013) · Utrecht University Repository (Utrecht University) · Cited by 1

Fusion Proteins as Research Tools

Dorsman, J. C. (2006) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0005685 · Cited by 1

Gene Expression Profiling Using Microdissection in Cancer Tissues

(2002) · Handbook of immunohistochemistry and in situ hybridization of human carcinomas · doi:10.1016/s1874-5784(04)80017-5 · Cited by 1

Mdm2 and ARF

Klotzbücher, A., & Kubbutat, M. H. G. (2002) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-59259-153-4_10 · Cited by 1

p53 in Head and Neck Cancer

Roh, J.-L., & Koch, W. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8815-6_12

Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation

Latonen, L. (2003) · Työväentutkimus Vuosikirja

Mathematical modelling of the core regulatory feedback mechanisms of p53 protein that decide cell fate

Chong, K. H. (2014) · Lincoln University Research Archive (Lincoln University)

Small Molecules as Research Tools for Studying the Biology of the Tumour Suppressor p53

Spinnler, C. (2011) · Figshare

Multiple modes of Mdmx regulation affect p53 activation

Gilkes, D. M. (2008) · Digital Commons - University of South Florida (University of South Florida)

Expression levels of MDM2 and MDMX proteins and their associated effects on P53 in human liposarcomas

Touqan, N. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University)

Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7

Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)

Molecular mechanisms of growth suppression by pharmacologically activated p53

Hedström, E. (2009) · Figshare

PDGFB AND P53 IN BRAIN TUMORIGENESIS

Hede, S. (2010) · Figshare

Mechanisms of p53-mediated intrinsic and extrinsic tumor suppression

Li, H. (2014) · Figshare

Analysis of p53 and c-MYC, two key transcription factors involved in tumorigenesis

Jung, P. (2008) · doi:10.5282/edoc.10559

Multiple independent pseudogene derivations indicate increased instability of the Mdm2 locus in Mus caroli

Ford, K. K., Mack, J. A., & O'Neill, R. J. W. (2005) · Molecular Biology Reports · doi:10.1007/s11033-005-0752-y

Modification of MDMX by Ubiquitination and Sumoylation

Pan, Y. (2005) · Digital Commons - University of South Florida (University of South Florida)

Construção e caracterização de vetor adenoviral com promotor responsivo ao seu próprio transgene p53 e sua comparação com um vetor de promoção constitutiva.

Soares, R. B. D. S. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2011.tde-14092011-144755

Novel Role of CHK2 in the Intrinsic and Extrinsic Apoptosis Pathway

Agarwal, A. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7ng4nnv

p53 and DNA damage checkpoint responses in the human prostate

af Hällström, T. (2007)

Pharmacological targeting of mutant p53 family members

Rökaeus, N. (2011) · Figshare

Small molecule inhibitors of Mdm2 E3 ubiquitin ligase activity

Dickens, M. P. (2011) · UPT. Syiah Kuala University Library (Syiah Kuala University)

GENOMIC CHARACTERIZATION OF RECURRENT CHROMOSOMAL ABERRATIONS IN RETINOBLASTOMA

D'Silva, C. N. (2010)

Minireview Mdm2:TheUpsandDowns

Juven‐Gershon, T. (1999)

Induction of p53 Dependent Cellular Senescence Through HdmX Inhibition or YPEL3 Expression

Miller, K. L. (2010) · Journal of Bioresource Management

Loss of Tumor Suppressor RPL5/RPL11 Does Not Induce Cell-Cycle Arrest, but Impedes Proliferation Due to Reduced Ribosome Content and Translation Capacity: Implications in Diamond Blackfan Anemia

Teng, T. (2013) · OhioLink ETD Center (Ohio Library and Information Network)

Characterization of the Ubiquitin/Nedd8 E3 ligase activity of the Mdm2/MdmX complex

Singh, R. K. (2007) · Kölner Universitäts PublikationsServer (Universität zu Köln)

Charakterisierung der biochemischen und biologischen Funktionen von Polyubiquitinketten

Sektion, M.-N. (2010)

A regulatory network of Mdm2 and members of the Polycomb Group (PcG) family

Wienken, M. M. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5475

Mechanisms of p53-mediated Intrinsic and Extrinsic Tumor Suppression

Selivanova, G., Höglund, P., Piaggio, G., Elena, R., Pereira, T., Wright, A. R., Wadelius, C., & Universitit, U. (2014)

FUNCTIONAL ANALYSIS OF SKP2 REGARDING P21 REGULATION IN THE DEVELOPING NERVOUS SYSTEM OF THE MOUSE: SKP2 ELIMINATION PROMOTES MDM2/MDM4-MEDIATED PROTEASOMAL DEGRADATION OF P21

Pozzi, M. (2011) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/pozzi-marco_phd2011-01-17

Exploring Chromatin-bound MDM2 Functions in Compromised Transcriptional Regulation of p53 Target Genes

Rosso, M. (2015) · CUNY Academic Works (City University of New York)

Transcriptional regulation of LAMB3 by p53

Jani, M. (2008) · CORE Scholar (Wright State University)

Structural and Functional Characterization of the Human Mdm2 and MdmX RING Domains

Egorova, O. (2014) · YorkSpace (York University)

Functions of Ubiquitin Specific Protease 7 (USP7) in Epstein-Barr Virus Infection and Associated Cancers

Sarkari, F. (2011) · TSpace (University of Toronto)

Avaliação dos mecanismos moleculares das vias de p53/ARF e IFNbeta envolvidos com a resposta de células de melanoma ao tratamento com os transgenes p19Arf e IFNbeta

Ribeiro, A. H. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-04112016-142136

An investigation of mutant p53 function.

Noll, J. E. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)

Towards the Investigation of the Effects of Nitration on the Activity of the Human p53 Tumour Suppressor Protein. Nitration of the p53 Tumour Suppressor Protein

Husaini, R. (2014) · Bradford Scholars (University of Bradford)

Cooperating Oncogenic Alterations in Aggressive Pten-Deficient Breast Cancer

Wang, S. (2017) · TSpace (University of Toronto)

Generation of reporter cell lines by genome editing to probe p53 activity

Tolay, N. (2018) · Sabanci University

In Vivo Discoveries in MDM2-Mediated p53 Regulation

Tackmann, N. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/z7ta-7m83

Exploring nanobodies interrupting the interaction between p53 and MDM4

Sarıyar, S. (2019) · Sabanci University

Zusammenhänge zwischen TP53-Mutationsstatus, genetischer Instabilität und Prognose bei MDS und sekundärer AML mit komplex aberrantem Karyotyp

Schaab, R. (2020) · doi:10.53846/goediss-7883

Characterization of NEK10 Tyrosine Kinase Activity in the Cellular Response to DNA Damage

Haider, N. (2018) · TSpace (University of Toronto)

Characterization of synthetic lethality between Mdm2 overexpression and genotoxic agents and identification of a novel function of the Mdmx oncogene in DNA repair

Carrillo, A. M. (2014)

Generating Isogenic Models of Li-Fraumeni Syndrome and Restoring p53 using CRISPR

Tran, J. (2020) · TSpace (University of Toronto)

Computational Investigation on the MDM2-Idasanutlin Interaction Using the Potential of Mean Force Method

Das, P., & Mattaparthi, V. S. K. (2021) · Current Chemical Biology · doi:10.2174/2212796815666210716151211

Imaging of a siRNA molecular probe targeting MDM2 in breast cancerPreprint

Wang, X., Peng, X., Jiao, Y., Luan, S., Gao, Y., Zhao, C., & Fu, P. (2020) · Research Square · doi:10.21203/rs.3.rs-49584/v1

The tumour suppressor p53 as a supporter of DNA replication

Klusmann, I. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7143

Targeting MDM2, the antagonist of the tumor suppressor p53

Sriraman, A. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7056

MDM2 as a chromatin modifier

Gerber, S. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8184

Retinoblastoma

Estlin, E. J., Doz, F., & Dyer, M. A. (2010) · Pediatric Hematology and Oncology · doi:10.1002/9781444315134.ch18

P53

Hesketh, R. (1997) · Elsevier eBooks · doi:10.1016/b978-012344548-3/50085-6

MDM4 (Murine Double Minute 4)

Huang, A., Yang, E., & Kurokawa, M. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101575-1

Comparative study of the p53-mdm2 and p53-MDMX interfaces

Böttger, V., Böttger, A., Garcia-Echeverria, C., Ramos, Y. F., van der Eb, A. J., Jochemsen, A. G., & Lane, D. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202281 · Cited by 189

Isolation and Identification of the Human Homolog of a New p53-Binding Protein, Mdmx

Shvarts, A., Bazuine, M., Dekker, P., Ramos, Y. F., Steegenga, W. T., Merckx, G., van Ham, R. C. A., van Oordt, C. W. M. D. H., van der Eb, A. J., & Jochemsen, A. G. (1997) · Genomics · doi:10.1006/geno.1997.4775 · Cited by 152

Identification of a domain within MDMX‐S that is responsible for its high affinity interaction with p53 and high‐level expression in mammalian cells

Rallapalli, R., Strachan, G. D., Tuan, R. S., & Hall, D. J. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10535 · Cited by 45

MdmX Is Required for p53 Interaction with and Full Induction of the Mdm2 Promoter after Cellular Stress

Biderman, L., Poyurovsky, M. V., Assia, Y., Manley, J. L., & Prives, C. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06150-11 · Cited by 27

Constitutive mdmx Expression During Cell Growth, Differentiation, and DNA Damage

Jackson, M. W., & Berberich, S. J. (1999) · DNA and Cell Biology · doi:10.1089/104454999314971 · Cited by 27